Memantine Clinical Trials

• Vitamin E and Namenda (Memantine) for the Treatment of Patients With Mild to Moderate Alzheimer''s Disease on Aricept (Donepezil)
  ClinicalTrials.gov Identifier: NCT00235716 - Recruiting
  Alzheimer''s Disease
  
• Memantine for the Prevention of Negative Symptomatology
  ClinicalTrials.gov Identifier: NCT00148590 - Recruiting
  Schizophrenia
  
• Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
  ClinicalTrials.gov Identifier: NCT00134901 - Active, not recruiting
  Cocaine-Related Disorders
  
• Memantine for the Treatment of Negative Symptomatology
  ClinicalTrials.gov Identifier: NCT00148616 - Recruiting
  Chronic schizophrenia
  
• Effectiveness of Memantine in Treating Heroin-Dependent Individuals - 1
  ClinicalTrials.gov Identifier: NCT00126711 - Recruiting
  Heroin Dependence
  
• Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3
  ClinicalTrials.gov Identifier: NCT00136786 - Not yet recruiting
  Tobacco Use Disorder
  
• Memantine Augmentation in Obsessive-Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00264238 - Recruiting
  Obsessive-Compulsive Disorder [F03.080.600]
  
• Memantine Augmentation of Antidepressants
  ClinicalTrials.gov Identifier: NCT00344682 - Recruiting
  Depressive Disorder
  
• Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer’s Disease)
  ClinicalTrials.gov Identifier: NCT00334906 - Active, not recruiting
  Alzheimer's Disease
  
• Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
  ClinicalTrials.gov Identifier: NCT00097942 - Completed
  Schizophrenia
  
• A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00322153 - Active, not recruiting
  Alzheimer's Disease
  
• Memantine Versus Donepezil in Early Stages of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00505167 - Recruiting
  Dementia, Alzheimer Type
  
• Clinical Trial of Memantine for Major Depression
  ClinicalTrials.gov Identifier: NCT00040261 - Completed
  Depression
  
• The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in ALS
  ClinicalTrials.gov Identifier: NCT00409721 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00551161 - Recruiting
  Alzheimer Disease
  
• Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
  ClinicalTrials.gov Identifier: NCT00183729 - Recruiting
  Depression
  
• An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients with Moderate to Severe Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00097916 - Completed
  Alzheimer's Disease
  
• Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00196703 - Recruiting
  Aphasia; Stroke
  
• An Evaluation of the Safety and Efficacy of Memantine in Patients with Acute Mania Associated with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00106405 - Completed
  Bipolar Disorder
  
• Memantine or Riluzole Prophylaxis for Corticosteroid-Induced Mood and Declarative Memory Changes
  ClinicalTrials.gov Identifier: NCT00283309 - Recruiting
  Mood; Memory Deficit
  
• Memantine for Agitation in Dementia
  ClinicalTrials.gov Identifier: NCT00371059 - Recruiting
  Dementia
  
• Memantine as an Adjunctive Agent to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Severe Major Depressive Episode
  ClinicalTrials.gov Identifier: NCT00186498 - Recruiting
  Major Depressive Disorder
  
• The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
  ClinicalTrials.gov Identifier: NCT00255086 - Recruiting
  Alzheimer's Disease
  
• Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00300716 - Recruiting
  Multiple Sclerosis; Cognition Disorders
  
• Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00305578 - Recruiting
  Bipolar Depression
  
• Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00469456 - Recruiting
  Alzheimer's Disease
  
• Memantine and Down's Syndrome
  ClinicalTrials.gov Identifier: NCT00240760 - Recruiting
  Down's Syndrome; Dementia; Learning Disabilities
  
• A Pilot Clinical Trial Of Memantine for Essential Tremor
  ClinicalTrials.gov Identifier: NCT00439699 - Recruiting
  Essential Tremor
  
• Developing Medication For Tobacco Addiction - 1
  ClinicalTrials.gov Identifier: NCT00136747 - Recruiting
  Tobacco Use Disorder
  
• Memantine in Patients with Chronic Glaucoma
  ClinicalTrials.gov Identifier: NCT00141882 - Completed
  Open-Angle Glaucoma
  
• Memantine as a Supplement to Naltrexone in Treating Heroin Dependence
  ClinicalTrials.gov Identifier: NCT00476242 - Recruiting
  Opioid Dependence; Heroin Dependence
  
• A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00411398 - Recruiting
  General Anxiety Disorder, Social Anxiety Disorder
  
• Double-Blind, Parallel Group, Placebo-Controlled Trial of the Efficacy and Tolerability of Memantine (20 Mg) in Frontotemporal Dementia (FTD) Patients.
  ClinicalTrials.gov Identifier: NCT00200538 - Recruiting
  Patients with frontotemporal dementia
  
• Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)
  ClinicalTrials.gov Identifier: NCT00353665 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Memantine in Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00181298 - Not yet recruiting
  Systemic Lupus Erythematosus
  
• A Study to Evaluate the Use of Memantine In Combination with Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
  ClinicalTrials.gov Identifier: NCT00000867 - Completed
  AIDS Dementia Complex; HIV Infections
  
• Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
  ClinicalTrials.gov Identifier: NCT00545974 - Recruiting
  Frontal Lobe Dementia; Frontotemporal Lobe Dementia; Semantic Dementia
  
• Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia
  ClinicalTrials.gov Identifier: NCT00294554 - Recruiting
  Parkinson's Disease; Cognitive Impairment; Dementia
  
• Memantine for Agitation and Aggression in Severe Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00401167 - Not yet recruiting
  Alzheimer's Disease
  
• Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
  ClinicalTrials.gov Identifier: NCT00566852 - Not yet recruiting
  Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Neurotoxicity; Unspecified Adult Solid Tumor, Protocol Specific
  
• Memantine for Corticosteroid-Induced Mood and Declarative Memory Changes
  ClinicalTrials.gov Identifier: NCT00280774 - Completed
  Physiological Effects of Drugs
  
• Memantine in Patients With Chronic Glaucoma
  ClinicalTrials.gov Identifier: NCT00168350 - Completed
  Open-Angle Glaucoma
  
• Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00305903 - Completed
  Alzheimer's Disease
  
• Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.
  ClinicalTrials.gov Identifier: NCT00368862 - Completed
  Alcoholism; Depression
  
• Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
  ClinicalTrials.gov Identifier: NCT00234637 - Completed
  Alzheimer's Disease
  
• Parkinson's Disease Evaluated by PET and the Effect of Memantine
  ClinicalTrials.gov Identifier: NCT00375778 - Completed
  Parkinson's Disease
  
• A Placebo-Controlled Trial of Memantine for Alcohol Dependence
  ClinicalTrials.gov Identifier: NCT00246415 - Completed
  Alcohol Dependence (Primary Condition); Alcohol Abuse
  
• A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
  ClinicalTrials.gov Identifier: NCT00187525 - Completed
  Frontotemporal Lobar Degeneration
  
• Testing the Effectiveness of Medications Used to Treat Heroin Dependence - 1
  ClinicalTrials.gov Identifier: NCT00125515 - Completed
  Heroin Dependence
  
• An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder
  ClinicalTrials.gov Identifier: NCT00330655 - Completed
  Binge Eating Disorder
  
• Prophylactic Effect of Memantine in Chronic Tension-Type Headache
  ClinicalTrials.gov Identifier: NCT00315666 - Completed
  Tension-Type Headache